B. Riley Securities reiterated coverage on Cassava Sciences with a new price target

6/23/21 9:45:37 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

B. Riley Securities reiterated coverage of Cassava Sciences with a rating of Buy and set a new price target of $111.00 from $78.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SAVA

Date	Price Target	Rating	Analyst
11/26/2024		Buy → Neutral	H.C. Wainwright
10/8/2024	$116.00	Neutral → Buy	H.C. Wainwright
7/1/2024		Buy → Neutral	H.C. Wainwright
11/16/2022	$44.00	Buy → Neutral	B. Riley Securities
1/24/2022	$108.00 → $72.00	Buy	B. Riley Securities
7/20/2021	$97.00 → $124.00	Buy	HC Wainwright & Co.
7/15/2021	$100.00	Overweight → Neutral	Cantor Fitzgerald
7/7/2021	$80.00 → $190.00	Buy	Maxim Group